Masimo [MASI] vs Bio-Rad Laboratories [BIO] Detailed Stock Comparison
Masimo
NASDAQ
Loading...
Bio-Rad Laboratories
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Masimo wins in 6 metrics, Bio-Rad Laboratories wins in 13 metrics, with 0 ties. Bio-Rad Laboratories appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Masimo | Bio-Rad Laboratories | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 129.16 | 24.80 | Bio-Rad Laboratories |
| Price-to-Book Ratio | 7.82 | 1.04 | Bio-Rad Laboratories |
| Debt-to-Equity Ratio | 61.58 | 19.73 | Bio-Rad Laboratories |
| PEG Ratio | 32.36 | 23.58 | Bio-Rad Laboratories |
| EV/EBITDA | 55.26 | 17.53 | Bio-Rad Laboratories |
| Profit Margin (TTM) | -21.32% | 12.50% | Bio-Rad Laboratories |
| Operating Margin (TTM) | 17.12% | 12.19% | Masimo |
| EBITDA Margin (TTM) | 17.12% | 12.19% | Masimo |
| Return on Equity | -22.37% | 4.59% | Bio-Rad Laboratories |
| Return on Assets (TTM) | 1.84% | 1.59% | Masimo |
| Free Cash Flow (TTM) | $145.30M | $266.20M | Bio-Rad Laboratories |
| 1-Year Return | 24.66% | -12.26% | Masimo |
| Price-to-Sales Ratio (TTM) | 3.79 | 2.90 | Bio-Rad Laboratories |
| Enterprise Value | $8.50B | $7.19B | Masimo |
| EV/Revenue Ratio | 3.95 | 2.82 | Bio-Rad Laboratories |
| Gross Profit Margin (TTM) | 62.90% | 52.99% | Masimo |
| Revenue per Share (TTM) | $40 | $92 | Bio-Rad Laboratories |
| Earnings per Share (Diluted) | $-5.08 | $11.08 | Bio-Rad Laboratories |
| Beta (Stock Volatility) | 1.21 | 0.91 | Bio-Rad Laboratories |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Masimo vs Bio-Rad Laboratories Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Masimo | 1.32% | 6.32% | -3.86% | -0.34% | -14.69% | -8.72% |
| Bio-Rad Laboratories | -0.54% | 8.12% | 15.49% | 17.46% | 0.87% | -12.42% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Masimo | 24.66% | -1.19% | -29.80% | 270.50% | 555.88% | 668.58% |
| Bio-Rad Laboratories | -12.26% | -44.01% | -44.85% | 104.07% | 236.11% | 420.71% |
Performance & Financial Health Analysis: Masimo vs Bio-Rad Laboratories
| Metric | MASI | BIO |
|---|---|---|
| Market Information | ||
| Market Cap | $8.16B | $7.40B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 1,111,551 | 393,534 |
| 90 Day Avg. Volume | 719,827 | 304,458 |
| Last Close | $153.87 | $285.66 |
| 52 Week Range | $107.98 - $194.88 | $211.43 - $387.99 |
| % from 52W High | -21.04% | -26.37% |
| All-Time High | $305.21 (Nov 15, 2021) | $832.70 (Aug 30, 2021) |
| % from All-Time High | -49.59% | -65.69% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.08% | 0.02% |
| Quarterly Earnings Growth | 2.21% | 0.02% |
| Financial Health | ||
| Profit Margin (TTM) | -0.21% | 0.13% |
| Operating Margin (TTM) | 0.17% | 0.12% |
| Return on Equity (TTM) | -0.22% | 0.05% |
| Debt to Equity (MRQ) | 61.58 | 19.73 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $19.20 | $263.42 |
| Cash per Share (MRQ) | $2.75 | $50.76 |
| Operating Cash Flow (TTM) | $176.60M | $534.20M |
| Levered Free Cash Flow (TTM) | $92.86M | $223.40M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Masimo vs Bio-Rad Laboratories
| Metric | MASI | BIO |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 129.16 | 24.80 |
| Forward P/E | 32.36 | 23.58 |
| PEG Ratio | 32.36 | 23.58 |
| Price to Sales (TTM) | 3.79 | 2.90 |
| Price to Book (MRQ) | 7.82 | 1.04 |
| Market Capitalization | ||
| Market Capitalization | $8.16B | $7.40B |
| Enterprise Value | $8.50B | $7.19B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.95 | 2.82 |
| Enterprise to EBITDA | 55.26 | 17.53 |
| Risk & Other Metrics | ||
| Beta | 1.21 | 0.91 |
| Book Value per Share (MRQ) | $19.20 | $263.42 |
Financial Statements Comparison: Masimo vs Bio-Rad Laboratories
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MASI | BIO |
|---|---|---|
| Revenue/Sales | $372.00M | $585.40M |
| Cost of Goods Sold | $138.00M | $279.40M |
| Gross Profit | $234.00M | $306.00M |
| Research & Development | $33.90M | $73.50M |
| Operating Income (EBIT) | $80.70M | $23.70M |
| EBITDA | $90.70M | $98.50M |
| Pre-Tax Income | $68.40M | $83.40M |
| Income Tax | $21.20M | $19.40M |
| Net Income (Profit) | $-170.70M | $64.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MASI | BIO |
|---|---|---|
| Cash & Equivalents | $130.80M | $521.40M |
| Total Current Assets | $1.18B | $3.04B |
| Total Current Liabilities | $546.50M | $506.60M |
| Long-Term Debt | $657.70M | $1.33B |
| Total Shareholders Equity | $946.40M | $6.68B |
| Retained Earnings | $1.32B | $7.48B |
| Property, Plant & Equipment | $183.60M | $681.70M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MASI | BIO |
|---|---|---|
| Operating Cash Flow | $62.60M | $156.00M |
| Capital Expenditures | $17.00M | $-34.40M |
| Free Cash Flow | $27.00M | $95.50M |
| Debt Repayment | $-78.80M | $-100,000 |
| Common Stock Repurchase | N/A | $-101.90M |
Short Interest & Institutional Ownership Analysis
| Metric | MASI | BIO |
|---|---|---|
| Shares Short | 3.27M | 917,109 |
| Short Ratio | 6.08 | 3.32 |
| Short % of Float | 0.09% | 0.05% |
| Average Daily Volume (10 Day) | 1,111,551 | 393,534 |
| Average Daily Volume (90 Day) | 719,827 | 304,458 |
| Shares Outstanding | 53.60M | 28.01M |
| Float Shares | 45.31M | 18.51M |
| % Held by Insiders | 0.08% | 0.16% |
| % Held by Institutions | 1.02% | 0.93% |
Dividend Analysis & Yield Comparison: Masimo vs Bio-Rad Laboratories
| Metric | MASI | BIO |
|---|---|---|
| Last 12-Month Dividend | $0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $0.00 | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | $0.00 | N/A |
| Ex-Dividend Date | N/A | N/A |